메뉴 건너뛰기
BMC Health Services Research
Volumn 10, Issue , 2010, Pages
Health economics: The start of clinical freedom
Author keywords

[No Author keywords available]
Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DECISION MAKING; HEALTH ECONOMICS; HUMAN; PROFESSIONAL PRACTICE;
EID: 77953932628     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-183     Document Type: Article
Times cited : (7)
References (9)
  • 1
    • 0020567063 scopus 로고
    • The end of clinical freedom
    • 10.1136/bmj.287.6401.1237. 6416349
    • The end of clinical freedom. JR Hampton, Br Med J (Clin Res Ed) 1983 287 6401 1237 38 10.1136/bmj.287.6401.1237 6416349
    • (1983) Br Med J (Clin Res Ed) , vol.287 , Issue.6401 , pp. 1237-38
    • Hampton, J.R.1
  • 2
    • 0031019442 scopus 로고    scopus 로고
    • Evidence-based medicine: An incomplete method for informing treatment choices
    • 10.1016/S0140-6736(96)05153-7. 8996435
    • Evidence-based medicine: an incomplete method for informing treatment choices. A Maynard, Lancet 1997 349 9045 126 28 10.1016/S0140-6736(96)05153-7 8996435
    • (1997) Lancet , vol.349 , Issue.9045 , pp. 126-28
    • Maynard, A.1
  • 3
    • 0026278394 scopus 로고
    • Developing the health care market
    • 10.2307/2234443
    • Developing the health care market. A Maynard, Economic J 1991 101 1277 86 10.2307/2234443
    • (1991) Economic J , vol.101 , pp. 1277-86
    • Maynard, A.1
  • 5
    • 0033151653 scopus 로고    scopus 로고
    • Incremental cost-effectiveness analysis: The optimal strategy depends on the strategy set
    • 10.1016/S0895-4356(99)00021-9. 10408990
    • Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. SB Cantor TG Ganiats, J Clin Epidemiol 1999 52 6 517 22 10.1016/S0895-4356(99)00021-9 10408990
    • (1999) J Clin Epidemiol , vol.52 , Issue.6 , pp. 517-22
    • Cantor, S.B.1    Ganiats, T.G.2
  • 6
    • 36749011885 scopus 로고    scopus 로고
    • Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada
    • 10.1016/j.clinthera.2007.09.001. 18035208
    • Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada. SR Earnshaw Y Moride S Rochon, Clin Ther 2007 29 9 2096 106 10.1016/j.clinthera.2007.09.001 18035208
    • (2007) Clin Ther , vol.29 , Issue.9 , pp. 2096-106
    • Earnshaw, S.R.1    Moride, Y.2    Rochon, S.3
  • 7
    • 0011773960 scopus 로고    scopus 로고
    • To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy
    • 10674051
    • To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. WF Clark DN Churchill L Forwell G Macdonald S Foster, CMAJ 2000 162 2 195 98 10674051
    • (2000) CMAJ , vol.162 , Issue.2 , pp. 195-98
    • Clark, W.F.1    Churchill, D.N.2    Forwell, L.3    MacDonald, G.4    Foster, S.5
  • 8
    • 33646152480 scopus 로고    scopus 로고
    • The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes
    • 10.2337/diacare.29.02.06.dc05-1443. 16443870
    • The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. ES Huang M Shook L Jin MH Chin DO Meltzer, Diabetes Care 2006 29 2 259 64 10.2337/diacare.29.02.06. dc05-1443 16443870
    • (2006) Diabetes Care , vol.29 , Issue.2 , pp. 259-64
    • Huang, E.S.1    Shook, M.2    Jin, L.3    Chin, M.H.4    Meltzer, D.O.5
  • 9
    • 33645135246 scopus 로고    scopus 로고
    • Personalized medicine: How much can we afford? A bioethics perspective
    • 10.1517/17410541.2.1.43
    • Personalized medicine: how much can we afford? A bioethics perspective. J Lunshof, Per Med 2005 2 1 43 47 10.1517/17410541.2.1.43
    • (2005) Per Med , vol.2 , Issue.1 , pp. 43-47
    • Lunshof, J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.